ADTX News and Press, ADiTx Therapeutics Inc. From 04/06/21

HealthBar Becomes AditxtScore™ Channel Partner to Offer AditxtScore™ for COVID-19 Immunity Status Monitoring to Complement its Concierge and Drive-Thru Testing Services PR Newswire MOUNTAIN VIEW, Calif. , April 6, 2021 /PRNewswire/ -- Adit...

Collection Sites, LLC Named AditxtScore™ Channel Partner to Offer AditxtScore™ for COVID-19 Immunity Status Monitoring through its Mobile Testing Centers PR Newswire MOUNTAIN VIEW, Calif. , April 1, 2021 /PRNewswire/ -- Aditx Therapeutics, Inc....

TORONTO, April 01, 2021 (GLOBE NEWSWIRE) -- Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) today announced that its wholly owned subsidiary, Collection Sites, LLC will offer AditxtScore™ for COVID-19 through its mobile testing centres. Aditx Therapeutic...

Aditx Therapeutics ([[ADTX]] -3.7%) announced the upcoming launch of the first-in-human clinical trials of its therapeutic program for psoriasis.Its AditxtReprogramming therapeutics division will initiate Phase 1/2 trials Q4 2020 to evaluate the safety and efficacy of nucleic acid-b...

Aditxt to Initiate First-In-Human Clinical Trials with its Therapeutics Programs in Psoriasis by Year-End Aditxt Engages Regulatory Consultant in Preparation for Submission of an IND Application to the Regulatory Agency in Germany PR Newswire MOUNTAIN VIEW, Calif. ...

Detroit, Michigan--(Newsfile Corp. - March 22, 2021) - Aditxt (NASDAQ: ADTX) will be presenting at the Benzinga Biotech Small Cap Conference taking place on March 24-25, 2021. We invite our shareholders and all interested parties to explore biotech small cap investment opportunities throug...

Intec Pharma Ltd (NTEC) +142% on announcing merger agreement with Decoy Biosystems.Check-Cap Ltd. (CHEK) +113% after receiving FDA IDE approval for pivotal study of C-Scan®.Acer Therapeutics (ACER) +67%.Shaw Communications (SJR) +55% as Rogers to acquire the company in C$2...

Mountain View, CA, March 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a biotech innovation company focused on improving the health of the immune system, today announced that Eazy Testing Inc....

CollPlant Biotechnologies CLGN -28% on stock offering.iFresh (IFMK) -26%.Amicus Therapeutics FOLD -25% after PROPEL data in Pompe disease; Cantor cuts to Neutral.Limelight Networks LLNW -23% on Q4 earnings.Applied DNA Sciences APDN -19%. on FQ1 earnings.Diff...

Gainers: ESSA Pharma (EPIX) +47%. Ayala Pharmaceuticals (AYLA) +45%. GenMark Diagnostics (GNMK) +27%. ADiTx Therapeutics (ADTX) +27%. Celsion (CLSN) +26%.Losers: Tilray (TLRY) -39%. Anchiano Therapeutics (ANCN) -35%. Zynerba Pharmaceuticals (ZYNE) -28%. Pulmatrix (PULM) -26%. Aphria (APHA) -2...